WST
HealthcareWest Pharmaceutical Services, Inc.
$279.03
+$2.63 (+0.95%)
Jan 5, 2026
Price History (1Y)
Analysis
West Pharmaceutical Services, Inc. is a healthcare company operating in the medical instruments and supplies industry within the sector of Healthcare. The company has a significant scale, with a market capitalization of $20.07 billion, annual revenue of $3.02 billion, and approximately 10,600 employees. The company's financial health indicates a strong profitability profile, with gross margins at 35.6%, operating margins at 21.8%, and profit margins at 16.3%. Additionally, West Pharmaceutical Services reports returns on equity of 16.9% and return on assets of 10.2%. The balance sheet shows a manageable debt-to-equity ratio of 9.93, with $628.50 million in cash and $303.00 million in debt. The company's valuation context is characterized by a price-to-earnings ratio of 40.97 (TTM) and 35.88 (forward). The revenue growth rate has been 7.7% year-over-year, while earnings growth has been 3.8%. The dividend yield stands at 32.0%, with a payout ratio of 12.4%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About West Pharmaceutical Services, Inc.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
Visit website →Key Statistics
- Market Cap
- $20.07B
- P/E Ratio
- 40.97
- 52-Week High
- $348.90
- 52-Week Low
- $187.43
- Avg Volume
- 692.36K
- Beta
- 1.17
- Dividend Yield
- 32.00%
Company Info
- Industry
- Medical Instruments & Supplies
- Exchange
- NYQ
- Country
- United States
- Employees
- 10,600